{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for mycophenolic root_modifications_structuralModifications_molecularFragment_refPname in root_modifications_structuralModifications_molecularFragment_refPname (approximate match)
Status:
Investigational
Source:
INN:efinopegdutide [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Class:
PROTEIN
Status:
Investigational
Class:
PROTEIN
Status:
Investigational
Source:
JAN:SABATOLIMAB [JAN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:golocdacimab [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:zimberelimab [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:tesnatilimab [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT01678417: Phase 2 Interventional Unknown status Relapsed or Refractory Follicular Lymphoma or Mantle Cell Lymphoma
(2012)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:briquilimab [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:efocipegtrutide [INN]
Source URL:
Class:
PROTEIN